MENU
SRPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sarepta Therapeutics (SRPT) Ownership - Who owns Sarepta Therapeutics?

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
835
Web
https://www.sarepta.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.11B
P/E Ratio
57.01
Total Cash
653.19M
Projected Growth
N/A
Total Debt
1.04B
Revenue
2.18B
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash/Share
6.19
Total Debt/Equity
0.72
Revenue/Share
20.56 USD as % of share price
View a ticker or compare two or three
SRPT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of treatments for life-threatening illnesses and viruses

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
835
Web
https://www.sarepta.com